SEARCH

SEARCH BY CITATION

References

  • 1
    Bangalore S, Messerli FH, Kostis JB, et al. Cardiovascular protection using beta-blockers: a critical review of the evidence. J Am Coll Cardiol. 2007;50:563572.
  • 2
    Williams B, Lacy PS, Thom SM, et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation. 2006;113:12131225.
  • 3
    Blomqvist I, Westergren G, Sandberg A, et al. Pharmacokinetics and pharmacodynamics of controlled-release metoprolol: a comparison with atenolol. Eur J Clin Pharmacol. 1988;33(suppl): S19S24.
  • 4
    Darmansjah I, Wong E, Setiawati A, et al. Pharmacokinetic and pharmacodynamic properties of controlled release (CR/ZOK) metoprolol in healthy Oriental subjects: a comparison with conventional formulations of metoprolol and atenolol. J Clin Pharmacol. 1990;30(2 suppl): S39S45.
  • 5
    Karagiannis A, Mikhailidis DP, Kakafika AI, et al. Atenolol: differences in mode of action compared with other antihypertensives. An opportunity to identify features that influence outcome? Curr Pharm Des. 2007;13:229239.
  • 6
    Hwang CW, Edelman ER. Arterial ultrastructure influences transport of locally delivered drugs. Circ Res. 2002;90:826832.
  • 7
    Pöyhönen-Alho MK, Manhem K, Katzman P, et al. Central sympatholytic therapy has anti-inflammatory properties in hypertensive postmenopausal women. J Hypertens. 2008;26:24452449.
  • 8
    Lanza GA, Pitocco D, Navarese EP, et al. Association between cardiac autonomic dysfunction and inflammation in type 1 diabetic patients: effect of beta-blockade. Eur Heart J. 2007;28:814820.
  • 9
    King DE, Egan BM, Mainous AG III, et al. The effect of extended-release metoprolol succinate on C-reactive protein levels in persons with hypertension. J Clin Hypertens (Greenwich). 2006;8:257260.
  • 10
    Gomes A, Costa D, Lima JL, et al. Antioxidant activity of beta-blockers: an effect mediated by scavenging reactive oxygen and nitrogen species? Bioorg Med Chem. 2006;14:45684577.
  • 11
    Bank AJ, Kelly AS, Thelen AM, et al. Effects of carvedilol versus metoprolol on endothelial function and oxidative stress in patients with type 2 diabetes mellitus. Am J Hypertens. 2007;20:777783.
  • 12
    Burns J, Mary DA, Mackintosh AF, et al. Arterial pressure lowering effect of chronic atenolol therapy in hypertension and vasoconstrictor sympathetic drive. Hypertension. 2004;44:454458.
  • 13
    Wallin BG, Sundlöf G, Strömgren E, et al. Sympathetic outflow to muscles during treatment of hypertension with metoprolol. Hypertension. 1984;6:557562.
  • 14
    Heffernan KS, Patvardhan EA, Hession M, et al. Elevated augmentation index derived from peripheral arterial tonometry is associated with abnormal ventricular-vascular coupling. Clin Physiol Funct Imaging. 2010;30:313317.
  • 15
    Kuvin JT, Patel AR, Sliney KA, et al. Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude. Am Heart J. 2003;146:168174.
  • 16
    Heffernan KS, Karas RH, Patvardhan EA, et al. Peripheral arterial tonometry for risk stratification in men with coronary artery disease. Clin Cardiol. 2010;33:9498.
  • 17
    Kuvin JT, Patel AR, Sliney KA, et al. Peripheral vascular endothelial function testing as a noninvasive indicator of coronary artery disease. J Am Coll Cardiol. 2001;38:18431849.
  • 18
    Dhakam Z, McEniery CM, Yasmin, et al. Atenolol and eprosartan: differential effects on central blood pressure and aortic pulse wave velocity. Am J Hypertens. 2006;19:214219.
  • 19
    Dhakam Z, Yasmin , McEniery CM, et al. A comparison of atenolol and nebivolol in isolated systolic hypertension. J Hypertens. 2008;26:351356.
  • 20
    Mahmud A, Feely J. Beta-blockers reduce aortic stiffness in hypertension but nebivolol, not atenolol, reduces wave reflection. Am J Hypertens. 2008;21:663667.
  • 21
    Ting CT, Chen CH, Chang MS, et al. Short- and long-term effects of antihypertensive drugs on arterial reflections, compliance, and impedance. Hypertension. 1995;26:524530.
  • 22
    Mackenzie IS, McEniery CM, Dhakam Z, et al. Comparison of the effects of antihypertensive agents on central blood pressure and arterial stiffness in isolated systolic hypertension. Hypertension. 2009;54:409413.
  • 23
    Wilkinson IB, MacCallum H, Flint L, et al. The influence of heart rate on augmentation index and central arterial pressure in humans. J Physiol. 2000;525(part 1):263270.
  • 24
    Wilkinson IB, Mohammad NH, Tyrrell S, et al. Heart rate dependency of pulse pressure amplification and arterial stiffness. Am J Hypertens. 2002;15(part 1):2430.
  • 25
    Papaioannou TG, Vlachopoulos CV, Alexopoulos NA, et al. The effect of heart rate on wave reflections may be determined by the level of aortic stiffness: clinical and technical implications. Am J Hypertens. 2008;21:334340.
  • 26
    Christensen KL, Mulvany MJ. Vasodilatation, not hypotension, improves resistance vessel design during treatment of essential hypertension: a literature survey [published correction appears in J Hypertens. 2001;19:1697]. J Hypertens. 2001;19:10011006.
  • 27
    Mathiassen ON, Buus NH, Larsen ML, et al. Small artery structure adapts to vasodilatation rather than to blood pressure during antihypertensive treatment. J Hypertens. 2007;25:10271034.
  • 28
    Priviero FB, Teixeira CE, Toque HA, et al. Vasorelaxing effects of propranolol in rat aorta and mesenteric artery: a role for nitric oxide and calcium entry blockade. Clin Exp Pharmacol Physiol. 2006;33:448455.
  • 29
    Kelly R, Daley J, Avolio A, et al. Arterial dilation and reduced wave reflection: benefit of dilevalol in hypertension. Hypertension. 1989;14:1421.
  • 30
    Muiesan ML, Salvetti M, Paini A, et al. Prognostic role of flow-mediated dilatation of the brachial artery in hypertensive patients. J Hypertens. 2008;26:16121618.
  • 31
    Modena MG, Bonetti L, Coppi F, et al. Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women. J Am Coll Cardiol. 2002;40:505510.
  • 32
    Kitta Y, Obata JE, Nakamura T, et al. Persistent impairment of endothelial vasomotor function has a negative impact on outcome in patients with coronary artery disease. J Am Coll Cardiol. 2009;53:323330.
  • 33
    Ghiadoni L, Magagna A, Versari D, et al. Different effect of antihypertensive drugs on conduit artery endothelial function. Hypertension. 2003;41:12811286.
  • 34
    Higashi Y, Sasaki S, Nakagawa K, et al. A comparison of angiotensin-converting enzyme inhibitors, calcium antagonists, beta-blockers and diuretic agents on reactive hyperemia in patients with essential hypertension: a multicenter study. J Am Coll Cardiol. 2000;35:284291.
  • 35
    Gokce N, Holbrook M, Hunter LM, et al. Acute effects of vasoactive drug treatment on brachial artery reactivity. J Am Coll Cardiol. 2002;40:761765.
  • 36
    Williams B, Lacy PS; for the CAFE and ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial) Investigators. Impact of heart rate on central aortic pressures and hemodynamics: analysis from the CAFE (Conduit Artery Function Evaluation) study: CAFE-Heart Rate. J Am Coll Cardiol. 2009;54: 705713.
  • 37
    Colucci WS, Kolias TJ, Adams KF, et al. Metoprolol reverses left ventricular remodeling in patients with asymptomatic systolic dysfunction: the Reversal of Ventricular Remodeling with Toprol-XL (REVERT) trial. Circulation. 2007;116:4956.
  • 38
    Zacà V, Rastogi S, Mishra S, et al. Atenolol is inferior to metoprolol in improving left ventricular function and preventing ventricular remodeling in dogs with heart failure. Cardiology. 2009;112:294302.
  • 39
    Barrios V, Escobar C, Tomás JP, et al. Comparison of the effects of doxazosin and atenolol on target organ damage in adults with type 2 diabetes mellitus and hypertension in the CARDHIAC study: A 9-month , prospective, randomized, open-label, blinded-evaluation trial. Clin Ther. 2008;30:98107.
  • 40
    Ariff B, Zambanini A, Vamadeva S, et al. Candesartan- and atenolol-based treatments induce different patterns of carotid artery and left ventricular remodeling in hypertension. Stroke. 2006;37:23812384.
  • 41
    Haller MJ, Silverstein JH, Shuster JJ. Correlation between radial artery tonometry- and fingertip tonometry-derived augmentation index in children with type 1 diabetes. Diab Vasc Dis Res. 2007; 4:66.
  • 42
    Carty DM, Brennand JE, Delles C, Dominiczak AF. Peripheral arterial tone technology to assess endothelial function in pregnancy. J Hypertens. 2010;28:e85e86.